Proliferative Diabetic Retinopathy Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Proliferative Diabetic Retinopathy Market is segmented By Treatment (Anti-VEGF Therapy, Laser Surgery, Vitrectomy), By Drug Type (Biologic Drugs, Small Molecule Drugs), By Delivery Mechanism (Intravitreal, Injections, Systemic Drugs), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.
Proliferative Diabetic Retinopathy Market Size
Market Size in USD
CAGR11.55%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 11.55% |
| Market Concentration | Medium |
| Major Players | Novartis, Roche, Bayer, Regeneron Pharmaceuticals, Allergan |
please let us know !
Proliferative Diabetic Retinopathy Market Analysis
The Proliferative Diabetic Retinopathy Market is estimated to be valued at USD 2.42 Bn in 2024 and is expected to reach USD 5.2 Bn by 2031, growing at a compound annual growth rate (CAGR) of 11.55% from 2024 to 2031. The market is primarily driven by the rising cases of diabetes across the globe. Strong product pipeline and increasing availability of various treatment options are proving conducive for market growth.